The Recall Desk
CriticalFDA (Drugs)·D-0771-2016·Announced 2016-03-16

Tf Supplements Recalls Rhino 7 3000 Due to Undeclared Ingredients

Tf Supplements is recalling Rhino 7 3000 bottles because they contain undeclared desmethyl carbondenafil and dapoxetine and were marketed without an approved NDA or ANDA.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.

Plain-English summary

Tf Supplements is voluntarily recalling 350 bottles of Rhino 7 3000, a 6-count bottle product made in the USA and distributed by Rhino 7. The recall covers all lots of the product.

The FDA has identified that the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Additionally, the product contains undeclared desmethyl carbondenafil and dapoxetine. The recall is distributed nationwide.

Consumers who have purchased Rhino 7 3000 should stop using the product and contact Tf Supplements for further instructions or a refund.

The recalled product

Product
RHINO 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA
Manufacturer
Tf Supplements
Affected units
350

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by Tf Supplements under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Same manufacturer · Tf Supplements

See all →